AI
LGND icon

Atom Investors’s Ligand Pharmaceuticals LGND Stock Holding History

Atom Investors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,999
Closed -$357K – 638
2023
Q4 		$357K Sell
4,999
-171
-3% -$10.1K 0.06% 332
2023
Q3 		$310K Sell
5,170
-99
-2% -$6.52K 0.07% 318
2023
Q2 		$380K Sell
5,269
-3,266
-38% -$245K 0.14% 149
2023
Q1 		$628K Buy
8,535
+3,738
+78% +$266K 0.34% 78
2022
Q4 		$320K Sell
4,797
-11,954
-71% -$777K 0.16% 132
2022
Q3 		$900K Hold
16,751
– – 0.32% 104
2022
Q2 		$932K Hold
16,751
– – 0.41% 75
2022
Q1 		$1.18M Sell
16,751
-37
-0.2% -$2.69K 0.55% 38
2021
Q4 		$1.62M Sell
16,788
-1,967
-10% -$182K 0.27% 71
2021
Q3 		$1.63M Sell
18,755
-3,188
-15% -$247K 0.13% 86
2021
Q2 		$1.8M Sell
21,943
-4,237
-16% -$352K 0.23% 82
2021
Q1 		$2.49M Sell
26,180
-99,620
-79% -$9.42M 0.42% 53
2020
Q4 		$7.8M Buy
125,800
+59,300
+89% +$3.38M 0.79% 35
2020
Q3 		$3.95M Buy
66,500
+31,986
+93% +$2.18M 0.38% 65
2020
Q2 		$2.41M Buy
+34,514
New +$2.19M 0.16% 119

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Atom Investors's LGND Position: Q1 2024 in Review

Atom Investors sold out of Ligand Pharmaceuticals (LGND) in Q1 2024, closing a stake of 4,999 shares — an estimated $357K sold.

Atom Investors first reported a position in LGND in Q2 2020 and held it in 15 quarters. The position peaked at $7.8M in Q4 2020. 222 funds tracked by Wall St. Rank hold LGND as of Q1 2024.

  • Atom Investors reported no remaining Ligand Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Atom Investors sold 4,999 Ligand Pharmaceuticals shares in Q1 2024, an estimated $357K.
  • Atom Investors first reported a position in Ligand Pharmaceuticals in Q2 2020 and held it in 15 quarters.
  • Atom Investors's Ligand Pharmaceuticals position peaked at $7.8M in Q4 2020.
  • 222 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2024.

Based on Atom Investors's 13F filing for Q1 2024, filed 15 May 2024.